Early potential safety signals for gliptins and gliflozins using real-world pharmacy data compared to spontaneous reporting - Maria-Isabel Jimenez-Serrania; Sara-Maria Martinez-Gonzalez; Javier Herradon-Muñoz; Carlos Treceño-Lobato (PLoS ONE, 2026)